GenScript Biotech, a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies announced the successful conclusion of its 2025 JPM Global Forum held ...

Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation ... hormone receptor-positive breast cancer, said Bayer. North Dakota became ...

Opens in a new tab or window Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation ... positive breast cancer, said Bayer.

Although the presence of pancreatic adenoma or islet-cell carcinoma has been considered to be one facet of the Zollinger—Ellison syndrome, it is not proved that pancreatic abnormality is an ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Tumor HI Rezolute reported preclinical validation of the potential use of ersodetug for the treatment of hypoglycemia due to non-islet cell tumors (NICTs). Combined with demonstrated potential in ...

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism (HI) Ersodetug continues to advance in ...

The findings could point to new strategies for managing disorders such as diabetes, obesity and cancer ... alpha cells located in the pancreatic islet of Langerhans, the authors explained.

Islet cell transplantation has long been considered a promising ... the risk of serious potential complications including infections, kidney damage, and cancer. Another is that the procedure requires ...

Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...